Article,

First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States

, , , , and .
Antimicrobial Agents and Chemotherapy, 49 (8): 3538--3540 (August 2005)PMID: 16048978.
DOI: 10.1128/AAC.49.8.3538-3540.2005

Abstract

Carbapenemases are rare in the United States. This is the first report of a United States nosocomial outbreak of pan-resistant Pseudomonas aeruginosa infections due to an integron-borne metallo-beta-lactamase, VIM-2. This emergence of carbapenemases on mobile genetic elements in the United States warrants surveillance.

Tags

Users

  • @jelias

Comments and Reviews